Shuttle Pharmaceuticals Holdings (SHPH) Interest & Investment Income (2023 - 2026)
Shuttle Pharmaceuticals Holdings' (SHPH) quarterly Interest & Investment Income came in at $209.0 in Q1 2026, down 60.04% quarter-over-quarter from $523.0 in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Interest & Investment Income (2023 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Interest & Investment Income history runs 4 years deep, the most recent figure standing at $209.0 for Q1 2026.
- On a quarterly basis, Interest & Investment Income changed N/A year-over-year to $209.0 in Q1 2026; TTM through Mar 2026 was $1299.0, a N/A change from a year earlier, with the FY2025 full-year figure at $1090.0, down 97.14% from the prior year.
- Interest & Investment Income retreated to $209.0 in Q1 2026 per SHPH's latest filing, from $523.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $22397.0 in Q4 2023 and bottomed at $3.0 in Q4 2024.
- The 4-year median for Interest & Investment Income is $8341.0 (2024), against an average of $9879.5.
- Across the five-year window, Interest & Investment Income sank 99.99% in 2024 and soared 17333.33% in 2025, its largest moves.
- Year by year, Interest & Investment Income stood at $22397.0 in 2023, then sank by 99.99% to $3.0 in 2024, then surged by 17333.33% to $523.0 in 2025, then sank by 60.04% to $209.0 in 2026.
- Per Business Quant, the three latest SHPH Interest & Investment Income figures stand at $209.0 (Q1 2026), $523.0 (Q4 2025), and $486.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 32.85 Mn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 41.80 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 28.10 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | - |
| 10 | Shuttle Pharmaceuticals Holdings | 1.42 Mn | 1.42 Mn | - | 209.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 209.00 |
| Dec 31, 2025 | 523.00 |
| Sep 30, 2025 | 486.00 |
| Jun 30, 2025 | 81.00 |
| Dec 31, 2024 | 3.00 |
| Sep 30, 2024 | 2,524.00 |
| Jun 30, 2024 | 14,158.00 |
| Mar 31, 2024 | 21,453.00 |
| Dec 31, 2023 | 22,397.00 |
| Sep 30, 2023 | 20,765.00 |
| Jun 30, 2023 | 19,267.00 |
| Mar 31, 2023 | 16,688.00 |